WeVote

Bill

Bill

HR 950

Saving Seniors Money on Prescriptions Act

119th Congress Introduced by Diana Harshbarger and 1 co-sponsor

HR 950 aims to lower prescription costs for seniors by allowing Medicare to negotiate prices, capping out-of-pocket expenses, and expanding covered medications.

Introduced in House
0
WeVote Research Nonpartisan
Bill Summary · HR 950

Summary of HR 950: Saving Seniors Money on Prescriptions Act

Purpose and Intent

The Saving Seniors Money on Prescriptions Act (HR 950) aims to reduce the financial burden of prescription medications for senior citizens. The bill seeks to implement measures that would lower out-of-pocket costs for seniors, ensuring they have better access to necessary medications without facing excessive financial strain.

Key Provisions

While the specific text of the bill is not provided, based on the title and typical legislative goals in this area, the following provisions are likely to be included:

  • Price Negotiation: The bill may empower Medicare to negotiate directly with pharmaceutical companies to lower drug prices for seniors.

  • Out-of-Pocket Caps: Introduction of a cap on out-of-pocket expenses for seniors, limiting the amount they have to pay for prescription drugs annually.

  • Increased Transparency: Requirements for drug manufacturers to disclose pricing information and any price increases, promoting transparency in the pharmaceutical market.

  • Expanded Coverage: Potential expansion of the list of covered medications under Medicare, ensuring that more essential drugs are accessible to seniors.

Who Would Be Affected

  • Senior Citizens: The primary beneficiaries of this legislation would be seniors enrolled in Medicare, who often face high costs for prescription medications.

  • Pharmaceutical Companies: The bill could impact how these companies price their drugs and negotiate with the government.

  • Healthcare Providers: Doctors and pharmacists may need to adapt to new guidelines and pricing structures as a result of the bill's provisions.

Procedural Aspects

  • Introduced Date: The bill was introduced in the House on February 4, 2025.

  • Committee Referral: Upon introduction, HR 950 was referred to the Committee on Energy and Commerce and the Committee on Ways and Means. The Speaker will determine the period for consideration of the bill by these committees.

Conclusion

HR 950 represents a significant legislative effort to alleviate the financial challenges faced by seniors regarding prescription medications. By potentially enabling price negotiations and capping out-of-pocket expenses, the bill aims to enhance the affordability and accessibility of essential drugs for older Americans. As the bill progresses through the legislative process, further details will emerge regarding its specific provisions and potential impacts.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.